Basis: (FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown. Source: stored company filings and market data; unavailable inputs remain N/A.
The PEG ratio is N/A as of 2026-10-06T20:04:53.677Z.
Calculation as of: 2026-10-06T20:04:53.677Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 003a868168475127aed2d79de39bcff4fedef78ca4fa12a3d766c53c2c747fe8
PEG RATIO
N/A
Verastem, Inc.
Market Cap
$681.02M
PEG Ratio
N/A
| NAME | MARKET CAP | PEG RATIO |
|---|---|---|
| Verastem, Inc. (VSTM) | $681.02M | N/A |
| Solid Biosciences Inc. (SLDB)vs › | $681.27M | N/A |
| Anteris Technologies Global Corp. (AVR)vs › | $685.49M | N/A |
| MiMedx Group, Inc. (MDXG)vs › | $673.41M | N/A |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $691.79M | N/A |
| Faeth Therapeutics, Inc. (FTH)vs › | $693.19M | N/A |
| Wave Life Sciences Ltd. (WVE)vs › | $693.61M | N/A |
| Cytek Biosciences, Inc. (CTKB)vs › | $694.79M | N/A |
| Helus Pharma Inc. (HELP)vs › | $666.95M | N/A |
| Annexon, Inc. (ANNX)vs › | $660.29M | N/A |
PEG Ratio
N/A
P/E Ratio
N/A
PEG Ratio = P/E Ratio / 5-Year Diluted EPS CAGR (%)
The PEG ratio divides the price-to-earnings ratio by the company's five-year compound annual growth rate of diluted EPS, expressed in percent. A P/E of 20 and a five-year diluted EPS CAGR of 10% give a PEG of 2.0. The growth is reported, historical earnings growth from annual statements, not an analyst forecast. A PEG near 1 is often read as fairly priced for its growth; lower can mean cheaper relative to growth. The ratio is N/A when the P/E is unavailable or not positive, or when the five-year diluted EPS CAGR is unavailable or not positive. Each day of the history uses the CAGR that was known on that day.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
